Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

Nat Med. 2020 Jul;26(7):1149. doi: 10.1038/s41591-020-0973-6.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

  • Published Erratum